MMP2 and prostate carcinoma: Taken together this report unveils a therapeutic potential of 3-azidoWA, derivative of dietary compound withaferin A to inhibit motility ability of cervical and prostate cancer cells through matrix metalloproteinase-2 by induction of extracellular Par-4, which has broader aspects of controlling tumorigenesis.